Cholera/enterotoxigenic Escherichia coli vaccine - Celldex Therapeutics

Drug Profile

Cholera/enterotoxigenic Escherichia coli vaccine - Celldex Therapeutics

Alternative Names: Cholera/ETEC vaccine; Combined ETEC-cholera vaccine [Peru-15-pCTB (Cholera toxin B-subunit)] - Celldex/NIAID; Combined live, attenuated, enterotoxigenic Escherichia coli (ETEC)-cholera Vaccine (Peru-15 pCTB) - Celldex Therapeutics/NIAID; ETEC/cholera vaccine; Peru-15 pCTB; Traveller's diarrhoea vaccine - Celldex Therapeutics

Latest Information Update: 04 Nov 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Celldex Therapeutics Inc
  • Developer Celldex Therapeutics Inc; National Institute of Allergy and Infectious Diseases
  • Class Cholera vaccines; Escherichia coli vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Cholera; Escherichia coli infections

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Cholera(Prevention, In volunteers) in USA (PO)
  • 04 Nov 2017 No recent reports of development identified for phase-I development in Escherichia-coli-infections(Prevention, In volunteers) in USA (PO)
  • 03 Feb 2011 NIAID completes a Phase-I clinical trial in the prevention of Escherichia coli infections and cholera (in volunteers) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top